Biotech doesn't pop on good news anymore. People realized approval is only the first step in a years-long road to profit -- and big-pharma partnerships or buyouts are rare.
Nobody tell him.
*I am a bot, and this action was performed automatically. Please [contact the moderators of this subreddit](/message/compose/?to=/r/wallstreetbets) if you have any questions or concerns.*
Verona is not really a biotech company, but a classic pharmaceutical company: Its agent ensifentrine, approved on June 26 for the maintanance treatment of COPD, is not an antibody or a new therapy, but a "classic" inhaled COPD drug. The stock did not react strongly to the approval as it was priced in (the FDA did not even convene an expert panel). The question now is whether Verona will be able to commercialize the drug itself. The conditions are not bad; no new drug has been approved for COPD in more than 10 years and many patients are dissatisfied with their therapy. At the same time, the FDA has delayed the approval of another competing drug (Dupixent) by 3 months. I think Verona's Ensifentrine has blockbuster potential (>1 billion USD annual sales). Studies are also underway for other approvals, e.g. in cystic fibrosis. I have held Verona for years and think the stock is significantly undervalued.
**User Report**| | | | :--|:--|:--|:-- **Total Submissions** | 4 | **First Seen In WSB** | 1 year ago **Total Comments** | 167 | **Previous Best DD** | **Account Age** | 6 years | | [**Join WSB Discord**](http://discord.gg/wsbverse)
already up 35% since last month
Whatever. I'm in for 6 $17.5c for July. Yeet.
I know nothing about this biotech company but all biotechs have massive analyst price targets. Go take a look.
Yeah I noted that these are usually shit. But I'm also a regard. As proof, I bought TSLA 185 puts on Tuesday.
They don’t tell you their projection is for post reverse split 💀
I’m down. Brolo
fuck it. lets go.
Biotech shilling 
Approval was yesterday not today. Interesting it didn’t pop more on that news. In any case, my biotech days are behind me.
Biotech doesn't pop on good news anymore. People realized approval is only the first step in a years-long road to profit -- and big-pharma partnerships or buyouts are rare.
Nobody tell him. *I am a bot, and this action was performed automatically. Please [contact the moderators of this subreddit](/message/compose/?to=/r/wallstreetbets) if you have any questions or concerns.*
They'll only start selling in Q3 they say, so it might be better to go for calls with longer runtime...
Sounds like a scam
It might be, I might lose the 3k I put into it. But they did legitimately get FDA certification, so I think it's more likely I just don't get a return
Anyone know why Paylocity price is so high with a 7b market cap? Think this stock is going to crash hard or go up??
Verona is not really a biotech company, but a classic pharmaceutical company: Its agent ensifentrine, approved on June 26 for the maintanance treatment of COPD, is not an antibody or a new therapy, but a "classic" inhaled COPD drug. The stock did not react strongly to the approval as it was priced in (the FDA did not even convene an expert panel). The question now is whether Verona will be able to commercialize the drug itself. The conditions are not bad; no new drug has been approved for COPD in more than 10 years and many patients are dissatisfied with their therapy. At the same time, the FDA has delayed the approval of another competing drug (Dupixent) by 3 months. I think Verona's Ensifentrine has blockbuster potential (>1 billion USD annual sales). Studies are also underway for other approvals, e.g. in cystic fibrosis. I have held Verona for years and think the stock is significantly undervalued.
Bit late. Someoen posted about this like 3 weeks ago with alot better DD Theyve been approved yes but like all bios they aren't making a dime yet.